Tradestie Institutional Equity Comparison Engine

UYSC vs ABVX โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

UYSC Overall Edge

UYSC Captures Institutional Edge (3โ€“1 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to UYSC (UYSC) driven by superior Valuation, Growth & Margin, Momentum & Technical while ABVX counters with relative strength in Options & Structure. Fundamentally, UYSC trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus ABVX at N/M Forward P/E and -6270.4% operating margin (-6.8% YoY). In options structure, UYSC sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ABVX sits in UNCLASSIFIED (<1st %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner UYSC
UYSC N/M vs ABVX N/M Fwd P/E
Growth & Margin Winner UYSC
Op Margin 0.0% vs -6270.4% ยท YoY +0.0% vs -6.8%
Momentum & Technical Winner UYSC
1Y +10.5% vs -35.2% ยท 52W Pos 62% vs 12%
Options & Structure Winner ABVX
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (<1st %ile IV)
UYSC US Equity
UYSC
Institutional Equity
$11.04
+0.0% 1D
Market Cap $84.2M
1M Return +3.18%
1Y Return +10.51%
Forward P/E N/M
Unified AI Score
51.5 / 100 HOLD
Tech 45.0 Fund 47.0 Flow 50.0 Mom 46.0
ABVX NASDAQ
Abivax SA American Depositary Shares
Pharmaceutical Preparations
$73.20
-9.24% 1D
Market Cap $7.1B
1M Return -18.87%
1Y Return -35.19%
Forward P/E N/M
Unified AI Score
42.4 / 100 HOLD
Tech 25.0 Fund 38.0 Flow 50.0 Mom 30.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: UYSC +10.51% ABVX -35.19% Spread: +28.45 pp (UYSC Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
UYSC TTM Op. Margin: 0.0% ABVX TTM Op. Margin: -6270.4%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on UYSC vs ABVX. Trailing 12-month operating profitability (UYSC 0.0% vs ABVX -6270.4%) and valuation multiples (UYSC N/M vs ABVX N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: UYSC (7) vs ABVX (1)
Institutional Metric UYSC ABVX Criterion Row Winner
Market Capitalization Scale $84.2M $7.1B Larger Scale ABVX
Trailing P/E Ratio Valuation 35.5x N/M Lower Multiple UYSC
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% -6.8% Higher Growth UYSC
Operating Margin (TTM) Profitability 0.0% -6270.4% Higher Margin UYSC
Net Profit Margin Profitability 0.0% 0.0% Higher Margin Tie
Return on Equity (ROE) Capital Efficiency 38.2% -252.3% Higher ROE UYSC
52-Week Range Position Momentum 62% ($10โ€“$12) 12% ($63โ€“$149) Stronger Trend UYSC
Beta / 30D Volatility Risk Regime -0.01ฮฒ ยท 7% Vol 1.55ฮฒ ยท 55% Vol Lower Realized Risk UYSC
Unified Institutional Score Composite Signal 51.5 / 100 (HOLD) 42.4 / 100 (HOLD) Higher Composite UYSC

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full UYSC vs ABVX Buy Guide
UYSC UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live UYSC Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ABVX UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile <1st %ile
IV Regime Compressed (<25th %ile)
Live ABVX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither UYSC nor ABVX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.